Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL4944310 | 0.84 | ALDH1A1 (0.45) | ALDH1A1TSHR | |
| Ether SCHEMBL6553095 | 0.80 | ALDH1A1 (0.43) | ALDH1A1 | |
| Ether SCHEMBL28705136 | 0.80 | — | — | |
| Ether SCHEMBL422163 | 0.80 | ALDH1A1 (0.40) | ALDH1A1TSHR | |
| Alcohol SCHEMBL7158313 | 0.79 | — | — | |
| Ether SCHEMBL8089271 | 0.79 | ALDH1A1 (0.37) | ALDH1A1 | |
| Ether SCHEMBL2837591 | 0.79 | ALDH1A1 (0.37) | ALDH1A1 | |
| Ether SCHEMBL9750502 | 0.79 | — | — | |
| Ether SCHEMBL3794585 | 0.79 | ALDH1A1 (0.37) | ALDH1A1 | |
| Ether SCHEMBL3701280 | 0.79 | ALDH1A1 (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240165118-A1 | Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids | Sumitomo Pharma Co., Ltd. (JP) | 2024-05-23 | — | — | US | disclosed |
| US-11957684-B2 | Treatment of heavy menstrual bleeding associated with uterine fibroids | SUMITOMO PHARMA SWITZERLAND GMBH (CH) | 2024-04-16 | — | — | US | disclosed |
| CN-117659083-A | Self-assembled monolayer material based on conjugated connecting groups, preparation method of self-assembled monolayer material and solar cell | 南方科技大学 | 2024-03-08 | — | — | CN | disclosed |
| US-11918583-B2 | — | — | 2024-03-05 | — | — | US | disclosed |
| US-20230390354-A1 | CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME | ZYMEWORKS BC INC. (CA) | 2023-12-07 | — | — | US | disclosed |
| CN-110143999-B | Cytotoxic and antimitotic compounds and methods of use thereof | 酵活英属哥伦比亚省公司 | 2023-12-05 | — | — | CN | disclosed |
| US-11793812-B2 | Methods of treating endometriosis | SUMITOMO PHARMA SWITZERLAND GMBH (CH) | 2023-10-24 | — | — | US | disclosed |
| US-20230317700-A1 | CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME | ZYMEWORKS BC INC. (CA) | 2023-10-05 | — | — | US | disclosed |
| US-20230265173-A1 | SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES | ZYMEWORKS BC INC. (CA) | 2023-08-24 | — | — | US | disclosed |
| CN-110312512-B | Methods for treating uterine fibroids and endometriosis | 梦欧文科学有限责任公司 | 2023-05-09 | — | — | CN | disclosed |
| US-6150391-A | Diazabicyclo-octane derivatives as 5-HT receptor ligands | MERCK SHARP & DOHME LTD. | 2000-11-21 | — | — | US | disclosed |
| US-6096735-A | Benzoheterocyclic derivatives | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 2000-08-01 | — | — | US | disclosed |
| WO-1997028162-A1 | DIAZABICYCLO-OCTANE DERIVATIVES AS 5-HT RECEPTOR LIGANDS | MERCK SHARP & DOHME LIMITED (GB) | 1997-08-07 | — | — | WO | disclosed |
| EP-0765314-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-02 | — | — | EP | disclosed |
| US-5397798-A | Benzamide and sulfonamide hypoglycemic agents | ELI LILLY AND COMPANY (US) | 1995-03-14 | — | — | US | disclosed |
| EP-0491525-A1 | Benzamide and sulfonamide hypoglycemic agents | ELI LILLY AND COMPANY (US) | 1992-06-24 | — | — | EP | disclosed |
| US-4673668-A | ANTICANCER AGENTS | SUMITOMO PHARMACEUTICALS COMPANY (JP) | 1987-06-16 | — | — | US | disclosed |
| EP-0107486-B1 | AMINONAPHTHACENE DERIVATIVES AND THEIR PRODUCTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-04-29 | — | — | EP | disclosed |
| EP-0107486-A1 | Aminonaphthacene derivatives and their production | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-05-02 | — | — | EP | disclosed |
| US-4304772-A | Ethanocarbazole derivatives and antidepressant compositions | AYERST, MCKENNA & HARRISON, INC. (CA) | 1981-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265173-A1 | SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES | MPST, TPST2, SULT1A1 | ALDH1A1 1011/4885TSHR 2211/4885TDP1 2877/4885 |
| US-11957684-B2 | Treatment of heavy menstrual bleeding associated with uterine fibroids | GNRHR, SHBG, FSHR | ALDH1A1 658/4885TSHR 304/4885TDP1 3365/4885 |
| US-11918583-B2 | — | SHBG, GNRHR, FSHR | ALDH1A1 592/4885TSHR 312/4885TDP1 3207/4885 |
| US-11793812-B2 | Methods of treating endometriosis | GNRHR, SHBG, FSHR | ALDH1A1 617/4885TSHR 262/4885TDP1 3233/4885 |
| US-20230390354-A1 | CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME | CCNB1, PLK1, BOD1L1 | ALDH1A1 3393/4885TSHR 4613/4885TDP1 291/4885 |
| US-20240165118-A1 | Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids | GNRHR, SHBG, FSHR | ALDH1A1 658/4885TSHR 304/4885TDP1 3365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.